Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Complement Integr Med ; 14(2)2017 Apr 26.
Article in English | MEDLINE | ID: mdl-28731314

ABSTRACT

Background Food and chemical sensitivities have detrimental effects on health and the quality of life. The natural course of such sensitivities can potentially be altered through various types of allergen-specific immunotherapy, including low-dose immunotherapy. The molecular mechanism by which low-dose immunotherapy causes desensitization has not thus far been elucidated. While resting lymphocytes maintain a low cytosolic calcium ion concentration, antigen receptor signaling results in calcium ion influx, predominantly via store-operated calcium channels. We therefore hypothesized that desensitization by low-dose immunotherapy is associated with reduced influx of calcium ions into lymphocytes. The aim of this study was to test this hypothesis. Methods Intracellular lymphocytic calcium ion concentrations were assayed in a total of 47 patients, following incubation with picogram amounts of the test allergens, using a cell-permeable calcium-sensing ratiometric fluorescent dye and fluorescence spectroscopy, both at baseline and following successful provocation neutralization treatment with low-dose immunotherapy. Results Low-dose immunotherapy was associated with a reduction in lymphocytic intracellular calcium ion concentration following treatment of: 23 % for metabisulfite sensitivity (p<0.0004); 12 % for salicylate sensitivity (p<0.01); 23 % for benzoate sensitivity (p<0.01); 30 % for formaldehyde sensitivity (p<0.0001); 16 % for sensitivity to petrol exhaust (p<0.003); 16 % for natural gas sensitivity (p<0.001); 13 % for nickel sensitivity (p<0.05); 30 % for sensitivity to organophosphates (p<0.01); and 24 % for sensitivity to nitrosamines (p<0.05). Conclusions Low-dose immunotherapy may affect baseline levels of intracellular calcium in lymphocytes, supporting the premise that allergens affect cell signaling in immune cells and provocation neutralization immunotherapy helps to promote more normal immune cell signaling.


Subject(s)
Allergens , Calcium/metabolism , Desensitization, Immunologic , Environmental Illness/therapy , Lymphocytes/metabolism , Adult , Benzoates/adverse effects , Environmental Illness/metabolism , Female , Food Hypersensitivity/metabolism , Food Hypersensitivity/therapy , Formaldehyde/adverse effects , Humans , Male , Multiple Chemical Sensitivity/metabolism , Multiple Chemical Sensitivity/therapy , Natural Gas/adverse effects , Nickel/adverse effects , Nitrosamines/adverse effects , Organophosphates/adverse effects , Salicylates/adverse effects , Vehicle Emissions
2.
Int J Mol Sci ; 16(4): 8861-83, 2015 Apr 21.
Article in English | MEDLINE | ID: mdl-25906474

ABSTRACT

Cardiovascular (CV) calcification is known as sub-clinical atherosclerosis and is recognised as a predictor of CV events and mortality. As yet there is no treatment for CV calcification and conventional CV risk factors are not consistently correlated, leaving clinicians uncertain as to optimum management for these patients. For this reason, a review of studies investigating diet and serum levels of macro- and micronutrients was carried out. Although there were few human studies of macronutrients, nevertheless transfats and simple sugars should be avoided, while long chain ω-3 fats from oily fish may be protective. Among the micronutrients, an intake of 800 µg/day calcium was beneficial in those without renal disease or hyperparathyroidism, while inorganic phosphorus from food preservatives and colas may induce calcification. A high intake of magnesium (≥380 mg/day) and phylloquinone (500 µg/day) proved protective, as did a serum 25(OH)D concentration of ≥75 nmol/L. Although oxidative damage appears to be a cause of CV calcification, the antioxidant vitamins proved to be largely ineffective, while supplementation of α-tocopherol may induce calcification. Nevertheless other antioxidant compounds (epigallocatechin gallate from green tea and resveratrol from red wine) were protective. Finally, a homocysteine concentration >12 µmol/L was predictive of CV calcification, although a plasma folate concentration of >39.4 nmol/L could both lower homocysteine and protect against calcification. In terms of a dietary programme, these recommendations indicate avoiding sugar and the transfats and preservatives found in processed foods and drinks and adopting a diet high in oily fish and vegetables. The micronutrients magnesium and vitamin K may be worthy of further investigation as a treatment option for CV calcification.


Subject(s)
Vascular Calcification/prevention & control , Animals , Antioxidants/administration & dosage , Asymptomatic Diseases , Atherosclerosis/prevention & control , Diet, Western/adverse effects , Dietary Supplements , Fatty Acids, Omega-3/administration & dosage , Feeding Behavior , Humans , Vascular Calcification/etiology
3.
Eur J Gastroenterol Hepatol ; 17(1): 21-6, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15647635

ABSTRACT

Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating 'IBS associated symptoms'. These symptoms are similar to other symptom complexes like chronic fatigue and the so-called 'candida syndrome', and many seek help from alternative medicine. The possible role of Candida and yeasts in non-immune compromised individuals is disputed and is the subject of this review. Even if the involvement of yeasts in the aetiology of IBS still remains unclear, there is increasing evidence for yeasts being able to cause IBS-symptoms in sensitized patients via Candida products, antigens and cross-antigens. But more research is needed before antifungal treatment can be recommended as a first line treatment for IBS.


Subject(s)
Antigens, Fungal/immunology , Candidiasis/complications , Irritable Bowel Syndrome/microbiology , Candida/metabolism , Candidiasis/diagnosis , Candidiasis/therapy , Diet , Humans , Intestines/microbiology , Irritable Bowel Syndrome/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...